Kopin Corporation (NASDAQ: KOPN),
a leading developer of innovative wearable computing technologies and
solutions, today provided an update on its business initiatives and
reported financial results for the fourth quarter and full year ended
December 29, 2018.
“We saw positive developments in both our military and enterprise
operations in 2018, which positions us for continued momentum this
year,” said Dr. John C.C. Fan, CEO of Kopin Corporation. “For the
military we commenced shipping into the Family of Weapon Site Individual
(FWS-I) program, and we entered a new military market with the win for
an armored vehicle program. In addition, we continued ramping shipments
of displays into the Joint Strike Fighter F-35 program; our partner,
Collins Elbit Visions Systems, recently announced that the 1,000th
F-35 HMD had been delivered. The HMD manufactured by Collins Elbit
Vision Systems is the only proven system that can pair with the world’s
most advanced fighter jet.
“We also saw good traction with our enterprise customers as their
products move from testing to commercialization. Companies continue to
recognize the benefits of augmented reality (AR), including safety,
efficiency and cost savings. We look for the Tier one customer that
bought 5,000 displays in late 2018 to commercialize this year, and
strengthen our position in industrial wearables.”
Dr. Fan continued, “The consumer market has not developed on the
schedule that we, or industry experts, expected. Development of virtual
reality (VR) applications continues to lag and we believe one of the
catalysts to drive innovation is an increase in the supply of
high-resolution organic light emitting diode (OLED) displays at lower
cost. We believe the start of OLED display manufacturing this year at
BOE’s $150 million state-of-the-art facility will address this
situation. In fact, we see a strong parallel to the ramp of the LED
market, where large volume Chinese manufacturers drove down the cost and
led to wide-spread adoption. We believe the scale of the BOE and other
facilities can create this same pricing trend, which will help stimulate
new applications in consumer VR.
“We enter 2019 with strong military and industrial programs in place,
while our development efforts will focus on commercializing our
Lightning OLED products. We are excited about both the short and long
term opportunities ahead for Kopin,” concluded Dr. Fan.
Fourth Quarter Financial Results
Total revenues for the fourth quarter ended December 29, 2018 were $7.7
million, compared with $11.4 million for the fourth quarter ended
December 30, 2017. The decrease in revenues in the fourth quarter of
2018 compared to 2017 was primarily due to the completion of a military
program at our subsidiary NVIS.
Research and development (R&D) expenses for the fourth quarter of 2018
were $3.9 million compared to $4.7 million for the fourth quarter of
2017.
Selling, general and administrative (SG&A) expenses were $6.2 million
for the fourth quarter of 2018, compared to $4.4 million for the fourth
quarter of 2017. SG&A in the fourth quarter of 2018 included an increase
of $1.7 million in non-cash stock-based compensation.
The net loss attributable to controlling interest for the fourth quarter
of 2018 was $11.0 million, or $0.15 per share, compared with net loss of
$1.8 million, or $0.02 per share, for the fourth quarter of 2017. The
fourth quarter of 2018 included an impairment charge to goodwill and the
write-down of fixed assets of $3.6 million. The fourth quarter of 2017
included an impairment charge to goodwill of $0.6 million and a gain of
$1.7 million from the mark to market of a warrant received from a
company that licensed Kopin’s intellectual property.
During the fourth quarter of 2018 Kopin had 10 patents granted and filed
for 3 new applications. Kopin has over 300 patents and patents pending,
almost all of which are related to wearable applications.
Full Year Results
Total revenue for the twelve months ended December 29, 2018 were $24.5
million, compared to $27.8 million for 2017.
Research and development expenses for 2018 were $17.4 million compared
with $18.9 million in 2017.
Selling, general and administrative expenses were $27.2 million in 2018,
compared with $20.5 million in 2017. The increase in SG&A in 2018
compared to 2017 was primarily due an increase in non-cash stock-based
compensation of $2.6 million, product promotion of $1.2 million,
accretion of earnout of $0.8 million and legal and professional fees of
$0.8 million.
The net loss from controlling interest for the 12 months ended December
29, 2018 was $35.5 million or $0.49 per share, versus a net loss of
$25.2 million or $0.36 per share for 2017. The full year 2018 included
an impairment charge to goodwill and the write-down of fixed assets of
$3.6 million and a non-cash $2.8 million gain of equity investments. The
full year 2017 included an impairment charge to goodwill of $0.6 million
and a gain of $2.0 million from the mark to market of a warrant we
received from a company that licensed intellectual property from us.
Net cash used in operating activities for the twelve months ended
December 29, 2018 was approximately $28.2 million. Kopin’s cash and
equivalents and marketable securities were approximately $37.2 million
at December 29, 2018 as compared to $68.8 million at December 30, 2017,
with no long-term debt.
Effective December 31, 2017, Kopin adopted ASC Topic 606 using the
“modified retrospective” approach, meaning the standard was applied only
to the financial results of fiscal year 2018 with a cumulative
adjustment to retained earnings. Under this transition method, Kopin
applied the standard only to contracts that were not complete at the
initial adoption date.
The following tables show the impact of adoption of Topic 606 on our
results of operations for the three and twelve month periods ended
December 29, 2018 (amount in millions):
Three Months Ended December 29, 2018 | |||||||||||||||||
Statement of Operations | As Reported |
Balances Without |
Effect of Change |
||||||||||||||
Net product revenues | $ | 6.1 | $ | 4.9 |
$ |
(1.2 |
) |
||||||||||
Research and development revenues | 1.7 | 1.8 |
|
0.1 |
|||||||||||||
Cost of product revenues | 4.6 | 4.8 |
|
0.2 |
|||||||||||||
Net loss attributable to Kopin Corporation | $ | (11.0 | ) | $ | (12.3 | ) |
$ |
(1.3 |
) |
||||||||
Twelve Months Ended December 29, 2018 | |||||||||||||||||
Statement of Operations | As Reported |
Balances Without |
Effect of Change |
||||||||||||||
Net product revenues | $ | 19.2 | $ | 19.7 | $ | (0.5 | ) | ||||||||||
Research and development revenues | 5.3 | 5.6 |
|
(0.3 |
) | ||||||||||||
Cost of product revenues | 15.8 | 16.9 |
|
(1.0 |
) | ||||||||||||
Net loss attributable to Kopin Corporation | $ | (35.5 | ) | $ | (35.7 | ) | $ | 0.1 | |||||||||
Note: Amounts above may not calculate due to rounding. |
|||||||||||||||||
All amounts above are estimates and readers should refer to our Form
10-K for the year ended December 29, 2018, for final disposition as well
as important risk factors.
Conference Call
To participate, please dial 877-709-8150 (U.S. and Canada) or
201-689-8354 (International). The call will also be available as a live
and archived audio webcast on the “Investors” section of the Kopin
website, www.kopin.com.
Forward-Looking Statements
Statements in this press release may be considered “forward-looking
statements” within the meaning of Section 27A of the Securities Act of
1933, as amended (the “Securities Act”), and Section 21E of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), which
are subject to the safe harbor created by such sections. Words such as
“expect,” “believes,” “can,” “will,” “estimates,” and variations of such
words and similar expressions, and the negatives thereof, are intended
to identify such forward-looking statements. We caution readers not to
place undue reliance on any such “forward-looking statements,” which
speak only as of the date made, and advise readers that these
forward-looking statements are not guarantees of future performance and
involve certain risks, uncertainties, estimates, and assumptions by us
that are difficult to predict.Various factors, some of which are
beyond our control, could cause actual results to differ materially from
those expressed in, or implied by, such forward-looking statements. All
such forward-looking statements, whether written or oral, and whether
made by us or on our behalf, are expressly qualified by these cautionary
statements and any other cautionary statements that may accompany the
forward-looking statements. In addition, we disclaim any obligation to
update any forward-looking statements to reflect events or circumstances
after the date of this press release, except as may otherwise be
required by the federal securities laws. These forward-looking
statements are only predictions, subject to risks and uncertainties, and
actual results could differ materially from those discussed. Important
factors that could affect performance and cause results to differ
materially from management’s expectations are described in Part I, Item
1A, Risk Factors; Part II, Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of Operations; and other parts of our
Annual Report on Form 10-K for the fiscal year ended December 30, 2017,
as updated from time to time in the Company’s Securities and Exchange
Commission filings. These factors include: our ability to obtain raw
materials and other goods as well as services from our suppliers as
needed; our intent to continue focusing our development efforts on
proprietary wearable computing systems; the potential for customers to
choose our competitors as their supplier; our expectation that we will
have negative cash flow from operating activities in 2019; our ability
to prosecute and defend our proprietary technology aggressively or
successfully; our ability to retain personnel with experience and
expertise relevant to our business; our ability to invest in research
and development to achieve profitability even during periods when we are
not profitable; our ability to continue to introduce new products in our
target markets; the degree to which our wearable technology is embraced
by consumers and commercial users; our ability to develop and expand our
wearable technologies and to market and license our concept systems and
components; our ability to generate revenue growth and positive cash
flow, and reach profitability;the strengthening of the U.S.
dollar and its effects on the price of our products in foreign markets;
the impact of new regulations and customer demands relating to conflict
minerals; our ability to obtain a competitive advantage in the wearable
technologies market through our extensive portfolio of patents, trade
secrets and non-patented know-how; our ability to grow within our
targeted markets; smartphone makers’ intent to create products that work
as a complement to smartphones or that will eventually replace
smartphones with more convenient configurations; the importance of small
form factor displays in the development of military, consumer, and
industrial products such as thermal weapon sights, safety equipment,
virtual and augmented reality gaming, training and simulation products
and metrology tools; our ability to successfully offer and market our
SOLOS smart glasses directly via the Internet; our ability to offer
Golden-i Infinity through value added resellers; the suitability of our
properties for our needs for the foreseeable future; our expectation not
to pay cash dividends for the foreseeable future and to retain earnings
for the development of our businesses; our expectation that we will
expend between $1.5 million and $2.0 million on capital expenditures
over the next twelve months; if we do not soon achieve and maintain
positive cash flow and profitability, our financial condition will
ultimately be materially adversely affected, and we will be required to
reduce expenses, including our investments in research and development
or raise additional capital; our ability to support our operations and
capital needs for at least the next twelve months through our available
cash resources; our expectation that we will incur taxes based on our
foreign operations in 2019; and our expectation that we will have a
state tax provision in 2019.
Kopin Corporation | |||||||||||||||||
Supplemental Information | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||
December 29, 2018 | December 30, 2017 | December 29, 2018 | December 30, 2017 | ||||||||||||||
Revenues by Category (in millions) | |||||||||||||||||
Military Applications | $ | 3.3 | $ | 7.0 | $ | 8.7 | $ | 13.4 | |||||||||
Industrial Applications | 1.8 | 1.4 | 6.1 | 5.5 | |||||||||||||
Consumer Electronics Applications | 0.9 | 1.6 | 4.1 | 4.4 | |||||||||||||
Research and Development | 1.7 | 1.0 | 5.3 | 2.9 | |||||||||||||
Other | – | 0.4 | 0.3 | 1.6 | |||||||||||||
Total | $ | 7.7 | $ | 11.4 | $ | 24.5 | $ | 27.8 | |||||||||
Stock-Based Compensation Expense | |||||||||||||||||
Cost of product revenues | $ | 100,000 | $ | 85,000 | $ | 419,000 | $ | 491,000 | |||||||||
Research and development | 98,000 | 183,000 | 725,000 | 799,000 | |||||||||||||
Selling, general and administrative | 715,000 | (962,000 | ) | 3,647,000 | 1,006,000 | ||||||||||||
$ | 913,000 | $ | (694,000 | ) | $ | 4,791,000 | $ | 2,296,000 | |||||||||
Other Financial Information | |||||||||||||||||
Depreciation and amortization | $ | 270,000 | $ | 624,000 | $ | 1,959,000 | $ | 2,502,000 | |||||||||
Kopin Corporation |
|||||||||||||||||||||||
Condensed Consolidated Statements of Operations | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
December 29, 2018 | December 30, 2017 | December 29, 2018 | December 30, 2017 | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Net product revenues | $ | 6,050,608 | $ | 10,392,860 | $ | 19,211,115 | $ | 24,894,805 | |||||||||||||||
Research and development revenues | 1,690,549 | 1,003,866 | 5,253,890 | 2,946,685 | |||||||||||||||||||
7,741,157 | 11,396,726 | 24,465,005 | 27,841,490 | ||||||||||||||||||||
Expenses: | |||||||||||||||||||||||
Cost of product revenues | 4,611,700 | 6,738,951 | 15,831,441 | 18,118,418 | |||||||||||||||||||
Research and development | 3,868,228 | 4,665,764 | 17,445,303 | 18,879,715 | |||||||||||||||||||
Selling, general and administrative | 6,199,800 | 4,354,298 | 27,210,849 | 20,541,244 | |||||||||||||||||||
Impairment on assets and goodwill | 3,636,639 | 600,086 | 3,636,639 | 600,086 | |||||||||||||||||||
18,316,367 | 16,359,099 | 64,124,232 | 58,139,463 | ||||||||||||||||||||
Loss from operations | (10,575,210 | ) | (4,962,373 | ) | (39,659,227 | ) | (30,297,973 | ) | |||||||||||||||
Other income, net | (264,110 | ) | 1,263,816 | 4,178,153 | 1,954,858 | ||||||||||||||||||
Loss before (provision) benefit for income taxes and net loss | (10,839,320 | ) | (3,698,557 | ) | (35,481,074 | ) | (28,343,115 | ) | |||||||||||||||
(income) from noncontrolling interest | |||||||||||||||||||||||
(Provision) benefit for income taxes | (145,000 | ) | 1,821,500 | (30,000 | ) | 2,963,000 | |||||||||||||||||
Net loss | (10,984,320 | ) | (1,877,057 | ) | (35,511,074 | ) | (25,380,115 | ) | |||||||||||||||
Net loss (income) attributable to noncontrolling interest | (9,189 | ) | 74,409 | (51,050 | ) | 139,633 | |||||||||||||||||
Net loss attributable to the controlling interest | $ | (10,993,509 | ) | $ | (1,802,648 | ) | $ | (35,562,124 | ) | $ | (25,240,482 | ) | |||||||||||
Net loss per share: | |||||||||||||||||||||||
Basic and diluted | $ | (0.15 | ) | $ | (0.02 | ) | $ | (0.49 | ) | $ | (0.36 | ) | |||||||||||
Weighted average number of common shares outstanding: | |||||||||||||||||||||||
Basic and diluted | 73,316,656 | 72,349,294 | 73,156,545 | 69,914,956 | |||||||||||||||||||
Kopin Corporation | ||||||||||
Condensed Consolidated Balance Sheets | ||||||||||
(Unaudited) | ||||||||||
December 29, 2018 | December 30, 2017 | |||||||||
ASSETS | ||||||||||
Current assets: | ||||||||||
Cash and marketable securities | $ | 37,244,363 | $ | 68,755,684 | ||||||
Accounts receivable, net | 3,088,360 | 4,659,986 | ||||||||
Contract assets and unbilled receivables | 3,089,663 | – | ||||||||
Inventory | 4,797,238 | 5,080,797 | ||||||||
Prepaid and other current assets | 1,184,401 | 1,243,029 | ||||||||
Total current assets | 49,404,025 | 79,739,496 | ||||||||
Land, equipment and improvements, net | 2,906,342 | 5,077,043 | ||||||||
Goodwill and intangible assets | 331,344 | 2,663,883 | ||||||||
Equity investment | 5,565,499 | – | ||||||||
Other assets | 1,649,401 | 3,842,068 | ||||||||
Total assets | $ | 59,856,611 | $ | 91,322,490 | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
Current liabilities: | ||||||||||
Accounts payable | $ | 3,921,878 | $ | 4,918,605 | ||||||
Accrued expenses | 5,510,694 | 4,351,537 | ||||||||
Income tax payable | – | 1,416,892 | ||||||||
Deferred income taxes | 545,859 | 520,000 | ||||||||
Contract liabilities and billings in excess of revenue earned | 388,933 | 896,479 | ||||||||
Total current liabilities | 10,367,364 | 12,103,513 | ||||||||
Other long term liabilities | 1,214,827 | 1,569,253 | ||||||||
Lease commitments | 254,098 | 269,877 | ||||||||
Total Kopin Corporation stockholders’ equity | 48,169,375 | 78,099,269 | ||||||||
Noncontrolling interest | (149,053 | ) | (719,422 | ) | ||||||
Total stockholders’ equity | 48,020,322 | 77,379,847 | ||||||||
Total liabilities and stockholders’ equity | $ | 59,856,611 | $ | 91,322,490 | ||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190312005232/en/
Kopin Corporation
Richard Sneider, 508-870-5959
Treasurer
and Chief Financial Officer
Richard_Sneider@kopin.com
or
Market
Street Partners
Joann Horne, 415-445-3233
JHorne@marketstreetpartners.com